Northwestern Medicine Central DuPage Hospital is a 390-bed hospital in Winfield, Illinois, United States, one of twelve hospitals operated by Northwestern Medicine.

There are 390 beds in Central DuPage Hospital.

During the past decade, Central DuPage Hospital conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 29 clinical trials were completed, i.e. on average, 87.9% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 13 clinical trials were completed. i.e. 86.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central DuPage Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 8 trials, followed by "Central DuPage Hospital" with 6 trials sponsored, "Washington University School of Medicine" with 3 trials sponsored, "AtriCure, Inc." with 2 trials sponsored and "Duke University" with 2 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central DuPage Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 72 different institutions and companies that were collaborators in the rest 70 trials.

According to Clinical.Site data, the most researched conditions in "Central DuPage Hospital" are "Ischemic Stroke" (4 trials), "Atrial Fibrillation" (3 trials), "Ovarian Cancer" (3 trials), "Breast Adenocarcinoma" (2 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "Central DuPage Hospital" in a lesser frequency.

Most popular intervention types in "Central DuPage Hospital" are "Drug" (41 trials), "Other" (22 trials), "Biological" (11 trials), "Device" (11 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Laboratory Biomarker Analysis" (9 trials), "Bevacizumab" (5 trials), "Carboplatin" (5 trials) and "Paclitaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Central DuPage Hospital" are 60 trials for "All" genders, 10 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Central DuPage Hospital". undefined are not yet recruiting, 9 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 32 completed trials in Central DuPage Hospital, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Central DuPage Hospital, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 13 trials that are defined as “Not Applicable".